Chemoinformaics analysis of Magnesium tartrate
| Molecular Weight | 172.375 | nRot | 3 |
| Heavy Atom Molecular Weight | 168.343 | nRig | 2 |
| Exact Molecular Weight | 171.986 | nRing | 0 |
| Solubility: LogS | -0.407 | nHRing | 0 |
| Solubility: LogP | -1.688 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 4 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 24.7592 |
| nHD | 2 | BPOL | 7.48483 |
| QED | 0.307 |
| Synth | 4.961 |
| Natural Product Likeliness | 0.102 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.02 |
| HIA | 0.017 |
| CACO-2 | -5.521 |
| MDCK | 0.0018126 |
| BBB | 0.464 |
| PPB | 0.134966 |
| VDSS | 0.315 |
| FU | 0.791784 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.091 |
| CYP2c19-inh | 0.04 |
| CYP2c19-sub | 0.21 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.062 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.141 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.054 |
| CL | 1.832 |
| T12 | 0.808 |
| hERG | 0.008 |
| Ames | 0.063 |
| ROA | 0.049 |
| SkinSen | 0.789 |
| Carcinogencity | 0.009 |
| EI | 0.988 |
| Respiratory | 0.942 |
| NR-Aromatase | 0.017 |
| Antiviral | Yes |
| Prediction | 0.556321 |